Navigation Links
Sudden cardiac death without recognizable cause
Date:1/29/2009

In about 10% of cases, sudden cardiac death (SCD) in young people is due to a cardiac gene defect. This was the conclusion drawn by Silke Kauferstein of the Department of Forensic Medicine of the Johann Wolfgang Goethe University, Frankfurt, and her coauthors in the current Deutsches rzteblatt International (Dtsch Arztebl Int 2009; 106(4): 41-7).

Sudden cardiac death is defined as unexpected death occurring rapidlyusually within 1 h of the onset of symptomsin persons who had previously seemed to be healthy. It is one of the most frequent causes of death in Europe. Each year, about 100 000 people die of sudden cardiac death in Germany alone. Although SCD mostly affects older people, 5% to 15% of cases are in young people who had previously been asymptomatic.

Most cases of sudden cardiac death can be explained by cardiovascular changes. However, in 10% to 30% of cases, no cause of death can be established, even after a postmortem. Genetically linked diseases of cardiac ion channels are responsible for at least a third of these deaths. As the ion channels are involved in stimulation and conduction in the heart, malfunction can cause cardiac arrythmias, which may lead to ventricular fibrillation.

These primary electrical heart disorders are mostly subject to autosomal dominant inheritance. This means that family members have a 50% risk of being carriers of the modified gene causing the disorder. A genetic study of the affected family is therefore essential if further cases of sudden cardiac death are to be prevented.


'/>"/>

Contact: Elke Bartholomus, MA
bartholomaeus@aerzteblatt.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related biology news :

1. Sudden ecosystem flips imperil worlds poorest regions, say water experts
2. Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic
3. Drops in blood oxygen levels may be key to sudden death in some epilepsy patients
4. University of Pittsburgh cardiologists identify new cardiac arrest gene
5. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
6. Implanting embryonic cardiac cells prevents arrhythmias
7. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
8. A home early warning system for cardiac patients
9. Cardiac cell transplant studies show promise in cardiac tissue repair
10. Syntermed licenses Emory ERTb software for enhanced cardiac imaging
11. New mechanism for cardiac arrhythmia discovered
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... ... the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). ... to examine vital clinical research issues such as trial performance metrics, patient enrollment ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the leading ... by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue of ... joined uBiome in October 2016 from her previous position at Stanford University School ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
(Date:1/18/2017)... Jan. 18, 2017  Caris Life Sciences, a ... Foundation, the largest private funder of pancreatic cancer ... evaluating the impact of immunotherapy in the treatment ... enrollment services to identify potential trial candidates based ... treating physicians and study investigators. The Lustgarten Foundation ...
Breaking Biology Technology: